Anti-Ro/SSA and La/SSB antibodies

被引:199
作者
Franceschini, F
Cavazzana, I
机构
[1] Spedali Civili Brescia, Serv Reumatol Allergol Immunol Clin, I-25100 Brescia, Italy
[2] Univ Brescia, Cattedra Reumatol, I-25121 Brescia, Italy
关键词
Ro/SSA; la/SSB; anti-ENA; systemic lupus erythematosus; sjogren's syndrome (SS);
D O I
10.1080/08916930400022954
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Ro/La system is considered as an heterogeneous antigenic complex, constituted by three different proteins (52 kDa Ro, 60 kDa Ro and La) and four small RNAs particles. Anti-Ro/SSA are the most prevalent specificity among many autoimmune diseases, such as systemic lupus erythematosus (SLE), SS/SLE overlap syndrome, subacute cutaneous LE (SCLE), neonatal lupus and primary biliary cirrhosis. In contrast, anti-La/SSB is more associated with Sjorgren's syndrome (SS). The differences between 52 kDa, 60 kDa Ro and La could explain why different assays did not show equivalent performance in anti-Ro and anti-La autoantibodies detection. The RNA precipitation assay had the highest sensitivity and specificity, usually considered as the reference methods. CIE is considered the most reliable to detect anti-Ro/SSA antibodies in routine practice, performing better than immunoblotting (IB) and some ELISAs. It shows a high sensitivity (89%) and specificity (100%). ELISA is generally considered a safe, rapid, sensitive and specific technique. Therefore, its high sensitivity often corresponds to a very low clinical specificity and the assay can give false positive results. Therefore, it is very important to search anti-Ro and anti-La only in selected patients, using the assay with high specificity and good predictive value, in order to have clinically significant and true positive results.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 112 条
[91]  
REVEILLE JD, 1991, J IMMUNOL, V146, P3871
[92]   STRIKING SIMILARITIES ARE EXHIBITED BY 2 SMALL EPSTEIN-BARR VIRUS-ENCODED RIBONUCLEIC-ACIDS AND THE ADENOVIRUS-ASSOCIATED RIBONUCLEIC-ACIDS VAI AND VAII [J].
ROSA, MD ;
GOTTLIEB, E ;
LERNER, MR ;
STEITZ, JA .
MOLECULAR AND CELLULAR BIOLOGY, 1981, 1 (09) :785-796
[93]   Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy [J].
Rutjes, SA ;
Egberts, WTMV ;
Jongen, P ;
VandenHoogen, F ;
Pruijn, GJM ;
VanVenrooij, WJ .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01) :32-40
[94]   ANTI-SS-A ANTIBODY AND OTHER ANTI-NUCLEAR ANTIBODIES IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
SCOPELITIS, E ;
BIUNDO, JJ ;
ALSPAUGH, MA .
ARTHRITIS AND RHEUMATISM, 1980, 23 (03) :287-293
[95]   100 ANTI-RO (SS-A) ANTIBODY-POSITIVE PATIENTS - A 10-YEAR FOLLOW-UP [J].
SIMMONSOBRIEN, E ;
CHEN, S ;
WATSON, R ;
ANTONI, C ;
PETRI, M ;
HOCHBERG, M ;
STEVENS, MB ;
PROVOST, TT .
MEDICINE, 1995, 74 (03) :109-130
[96]   CLINICAL IMPLICATIONS OF THE PRESENCE OF ANTI-RO(SSA) ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
SKOPOULI, FN ;
ANDONOPOULOS, AP ;
MOUTSOPOULOS, HM .
JOURNAL OF AUTOIMMUNITY, 1988, 1 (04) :381-388
[97]   SYSTEMIC LUPUS-ERYTHEMATOSUS IN HEREDITARY-DEFICIENCY OF THE 4TH COMPONENT OF COMPLEMENT [J].
TAPPEINER, G ;
HINTNER, H ;
SCHOLZ, S ;
ALBERT, E ;
LINERT, J ;
WOLFF, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1982, 7 (01) :66-79
[98]  
Targoff Ira N., 1997, Current Opinion in Rheumatology, V9, P527, DOI 10.1097/00002281-199711000-00008
[99]   MATERNAL ANTIBODIES AGAINST FETAL CARDIAC ANTIGENS IN CONGENITAL COMPLETE HEART-BLOCK [J].
TAYLOR, PV ;
SCOTT, JS ;
GERLIS, LM ;
ESSCHER, E ;
SCOTT, O .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (11) :667-672
[100]  
TISHLER M, 1994, J RHEUMATOL, V21, P1040